search
Back to results

Pre-ROSC Intra-Nasal Cooling Effectiveness (PRINCE)

Primary Purpose

Cardiac Arrest

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
RhinoChill
Control
Sponsored by
BeneChill, Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest focused on measuring Cardiac Arrest, Pre-hospital, Mild hypothermia, Resuscitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥18 years
  • Collapse was witnessed
  • No pulse
  • Unresponsive to external stimuli

Exclusion Criteria:

  • Have an etiology of cardiac arrest due to trauma, severe bleeding, drug overdose (OD), cerebrovascular accident (CVA), drowning, smoke inhalation, electrocution, hanging
  • Already hypothermic
  • Head trauma
  • Cannot place intra nasal catheters
  • Do Not Attempt to Resuscitate (DNAR) orders
  • Known or clinically apparent pregnancy
  • Have a known coagulopathy (except therapeutically induced)
  • Are known to have a need for supplemental oxygen
  • Achieve return of spontaneous circulation (ROSC) prior to initiating cooling
  • Are reached by emergency medical services (EMS) personnel more than 20 minutes after collapse

Sites / Locations

  • CHU St Pierre
  • Erasme Hospital (Free University of Brussels)
  • CHU de Tivoli
  • UZ Gasthuisberg Leuven
  • CHR de la Citadelle
  • Helig Hartzieknehuis Roeselare
  • Faculty Hospital Královské Vinohrady
  • Medizinisches Zentrum Kreis Aachen gGmbH
  • Charite Campus Virchow Klinikum
  • Albert Ludwigs University Freiburg
  • Georg August-Universität Göttingen
  • Krankenhaus Martha-Maria Halle-Dölau gGmbH
  • Otto-von-Guericke-Universität Magdeburg
  • A.O Ospedale San Gerardo di Monza
  • Stockholm Prehospital Centrum

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

RhinoChill

Control

Arm Description

Intra-arrest cooling with the RhinoChill during advanced cardiac life support

Advanced cardiac life support, only

Outcomes

Primary Outcome Measures

Achieve Return of Spontaneous Circulation (ROSC)
ROSC was defined as the return of an organized rhythm on electrocardiography (ECG) with a palpable pulse that was maintained for at least 20 minutes.
Survived to Hospital Discharge
The study end-point was hospital discharge. This outcome measure is the patient count for those that were discharged alive from the hospital.
Survived Neurologically-Intact
The Cerebral Performance Categories (CPC) are used to describe neurological outcome. A CPC of 1 or 2 is considered "neurologically intact." - Good cerebral performance: little to no deficit. - Moderate cerebral disability: capable of independent activities of daily life - Severe cerebral disability: conscious, but dependent on others for daily support - Coma or vegetative state - Death or brain death

Secondary Outcome Measures

Primary Outcomes in Sub-group With VF/VT as First Rhythm
ROSC, survival, and neurologically-intact survival
Time to Therapeutic Temperature
The therapeutic temperature range for treatment in cardiac arrest is considered to be 32-34C. Time to therapeutic temperature was taken as the first time in which 34C was measured. Tympanic and core temperatures were taken in all patients.
Length of Stay
Length of stay data for patients admitted to the hospital will be calculated for: Days on ventilator Days in intensive care without ventilator Days in general ward
Serious Adverse Events (SAEs)
These were defined serious adverse events that are not direct sequelae of the cardiac arrest itself or the underlying cardiac disease. Therefore, these do not include recurrent arrests occcuring within 24 hours of resuscitation nor deaths due to lack of cardiac and/or neurological recovery.
24-hour Adverse Events (AE)
These were all non-serious adverse events that occurred between the time of enrollment and 24 hours after resuscitation. These did not include a failure to achieve ROSC.

Full Information

First Posted
December 11, 2008
Last Updated
June 8, 2011
Sponsor
BeneChill, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT00808236
Brief Title
Pre-ROSC Intra-Nasal Cooling Effectiveness
Acronym
PRINCE
Official Title
Trans-Nasal Cooling With the RhinoChill Device Following Cardiac Arrest: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
June 2011
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
September 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
BeneChill, Inc

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.
Detailed Description
Out of hospital cardiac arrest remains a significant cause of death. Mild hypothermia induced after resuscitation from cardiac arrest has been shown to improve neurologically intact survival. Studies in dogs and rodents have demonstrated improved outcomes when cooling is initiated intra-arrest. The RhinoChill is a non-invasive cooling device through which rapid cooling is achieved via the intranasal delivery of an evaporative coolant into the nasopharynx. Due to its non-invasive and portable nature, the RhinoChill can be used to begin cooling earlier than other cooling devices. Studies performed using the RhinoChill in a porcine model of cardiac arrest suggest that cooling with the RhinoChill prior to the first defibrillation attempt facilitates resuscitation and improves resuscitation rate and neurologically intact survival. This study is being performed to assess the feasibility of using the RhinoChill device in the pre-hospital setting to improve resuscitation from cardiac arrest.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest
Keywords
Cardiac Arrest, Pre-hospital, Mild hypothermia, Resuscitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
RhinoChill
Arm Type
Experimental
Arm Description
Intra-arrest cooling with the RhinoChill during advanced cardiac life support
Arm Title
Control
Arm Type
Other
Arm Description
Advanced cardiac life support, only
Intervention Type
Device
Intervention Name(s)
RhinoChill
Other Intervention Name(s)
intra-nasal cooling
Intervention Description
Nasal catheters are placed and cooling is begun during the resuscitation attempt
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
Advanced cardiac life support according to American Heart Association & European Resuscitation Council 2005 Guidelines
Primary Outcome Measure Information:
Title
Achieve Return of Spontaneous Circulation (ROSC)
Description
ROSC was defined as the return of an organized rhythm on electrocardiography (ECG) with a palpable pulse that was maintained for at least 20 minutes.
Time Frame
1-hour after arrest
Title
Survived to Hospital Discharge
Description
The study end-point was hospital discharge. This outcome measure is the patient count for those that were discharged alive from the hospital.
Time Frame
30 days after arrest
Title
Survived Neurologically-Intact
Description
The Cerebral Performance Categories (CPC) are used to describe neurological outcome. A CPC of 1 or 2 is considered "neurologically intact." - Good cerebral performance: little to no deficit. - Moderate cerebral disability: capable of independent activities of daily life - Severe cerebral disability: conscious, but dependent on others for daily support - Coma or vegetative state - Death or brain death
Time Frame
30-days after arrest
Secondary Outcome Measure Information:
Title
Primary Outcomes in Sub-group With VF/VT as First Rhythm
Description
ROSC, survival, and neurologically-intact survival
Time Frame
hospital discharge
Title
Time to Therapeutic Temperature
Description
The therapeutic temperature range for treatment in cardiac arrest is considered to be 32-34C. Time to therapeutic temperature was taken as the first time in which 34C was measured. Tympanic and core temperatures were taken in all patients.
Time Frame
within 8 hours after enrollment
Title
Length of Stay
Description
Length of stay data for patients admitted to the hospital will be calculated for: Days on ventilator Days in intensive care without ventilator Days in general ward
Time Frame
Hospital Discharge
Title
Serious Adverse Events (SAEs)
Description
These were defined serious adverse events that are not direct sequelae of the cardiac arrest itself or the underlying cardiac disease. Therefore, these do not include recurrent arrests occcuring within 24 hours of resuscitation nor deaths due to lack of cardiac and/or neurological recovery.
Time Frame
7 days after arrest
Title
24-hour Adverse Events (AE)
Description
These were all non-serious adverse events that occurred between the time of enrollment and 24 hours after resuscitation. These did not include a failure to achieve ROSC.
Time Frame
24 hours after arrest

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥18 years Collapse was witnessed No pulse Unresponsive to external stimuli Exclusion Criteria: Have an etiology of cardiac arrest due to trauma, severe bleeding, drug overdose (OD), cerebrovascular accident (CVA), drowning, smoke inhalation, electrocution, hanging Already hypothermic Head trauma Cannot place intra nasal catheters Do Not Attempt to Resuscitate (DNAR) orders Known or clinically apparent pregnancy Have a known coagulopathy (except therapeutically induced) Are known to have a need for supplemental oxygen Achieve return of spontaneous circulation (ROSC) prior to initiating cooling Are reached by emergency medical services (EMS) personnel more than 20 minutes after collapse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Denise Barbut, MD
Organizational Affiliation
BeneChill, Inc
Official's Role
Study Chair
Facility Information:
Facility Name
CHU St Pierre
City
Brussels
ZIP/Postal Code
1000
Country
Belgium
Facility Name
Erasme Hospital (Free University of Brussels)
City
Brussels
ZIP/Postal Code
1070
Country
Belgium
Facility Name
CHU de Tivoli
City
La Louviere
ZIP/Postal Code
7100
Country
Belgium
Facility Name
UZ Gasthuisberg Leuven
City
Leuven
ZIP/Postal Code
B-3000
Country
Belgium
Facility Name
CHR de la Citadelle
City
Liege
ZIP/Postal Code
4000
Country
Belgium
Facility Name
Helig Hartzieknehuis Roeselare
City
Roeselare
ZIP/Postal Code
8800
Country
Belgium
Facility Name
Faculty Hospital Královské Vinohrady
City
Prague
ZIP/Postal Code
10034
Country
Czech Republic
Facility Name
Medizinisches Zentrum Kreis Aachen gGmbH
City
Aachen
ZIP/Postal Code
52146
Country
Germany
Facility Name
Charite Campus Virchow Klinikum
City
Berlin
ZIP/Postal Code
13353
Country
Germany
Facility Name
Albert Ludwigs University Freiburg
City
Freiburg
ZIP/Postal Code
79106
Country
Germany
Facility Name
Georg August-Universität Göttingen
City
Göttingen
ZIP/Postal Code
37086
Country
Germany
Facility Name
Krankenhaus Martha-Maria Halle-Dölau gGmbH
City
Halle (Saale)
ZIP/Postal Code
06120
Country
Germany
Facility Name
Otto-von-Guericke-Universität Magdeburg
City
Magdeburg
ZIP/Postal Code
39120
Country
Germany
Facility Name
A.O Ospedale San Gerardo di Monza
City
Monza
ZIP/Postal Code
20052
Country
Italy
Facility Name
Stockholm Prehospital Centrum
City
Stockholm
ZIP/Postal Code
118 83
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
18482670
Citation
Tsai MS, Barbut D, Tang W, Wang H, Guan J, Wang T, Sun S, Inderbitzen B, Weil MH. Rapid head cooling initiated coincident with cardiopulmonary resuscitation improves success of defibrillation and post-resuscitation myocardial function in a porcine model of prolonged cardiac arrest. J Am Coll Cardiol. 2008 May 20;51(20):1988-90. doi: 10.1016/j.jacc.2007.12.057. No abstract available.
Results Reference
background
PubMed Identifier
20679548
Citation
Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, Eichwede F, Mols P, Schwab T, Vergnion M, Storm C, Pesenti A, Pachl J, Guerisse F, Elste T, Roessler M, Fritz H, Durnez P, Busch HJ, Inderbitzen B, Barbut D. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010 Aug 17;122(7):729-36. doi: 10.1161/CIRCULATIONAHA.109.931691. Epub 2010 Aug 2.
Results Reference
derived

Learn more about this trial

Pre-ROSC Intra-Nasal Cooling Effectiveness

We'll reach out to this number within 24 hrs